PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-2.12%
Revenue decline while Healthcare median is 0.00%. Seth Klarman would investigate if market share loss is temporary.
-8.45%
Cost reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive advantage potential.
21.56%
Growth of 21.56% versus flat Healthcare gross profit. Walter Schloss would verify quality.
24.18%
Margin change of 24.18% versus flat Healthcare margins. Walter Schloss would verify quality.
-68.16%
R&D reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
29.49%
G&A change of 29.49% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
-0.68%
Marketing expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
-62.02%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
6.28%
Operating expenses change of 6.28% versus flat Healthcare costs. Walter Schloss would verify control.
-2.66%
Total costs reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-76.74%
Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
27.58%
D&A growth exceeding 1.5x Healthcare median of 0.23%. Jim Chanos would check for overinvestment.
630.78%
EBITDA growth exceeding 1.5x Healthcare median of 0.66%. Joel Greenblatt would investigate advantages.
642.25%
Margin change of 642.25% versus flat Healthcare. Walter Schloss would verify quality.
123.81%
Operating income growth exceeding 1.5x Healthcare median of 1.84%. Joel Greenblatt would investigate advantages.
124.33%
Margin change of 124.33% versus flat Healthcare. Walter Schloss would verify quality.
23.48%
Other expenses growth exceeding 1.5x Healthcare median of 9.38%. Jim Chanos would check for issues.
40094.44%
Pre-tax income growth exceeding 1.5x Healthcare median of 1.72%. Joel Greenblatt would investigate advantages.
40963.06%
Margin change of 40963.06% versus flat Healthcare. Walter Schloss would verify quality.
67.73%
Tax expense change of 67.73% versus flat Healthcare. Walter Schloss would verify strategy.
645.04%
Net income growth exceeding 1.5x Healthcare median of 2.60%. Joel Greenblatt would investigate advantages.
661.14%
Margin change of 661.14% versus flat Healthcare. Walter Schloss would verify quality.
22200.00%
EPS growth exceeding 1.5x Healthcare median of 4.26%. Joel Greenblatt would investigate advantages.
22200.00%
Diluted EPS growth exceeding 1.5x Healthcare median of 4.26%. Joel Greenblatt would investigate advantages.
5.52%
Share count reduction below 50% of Healthcare median of 0.12%. Jim Chanos would check for issues.
6.15%
Diluted share reduction below 50% of Healthcare median of 0.09%. Jim Chanos would check for issues.